Transcranial Magnetic Stimulation for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This is an observational neuroimaging study assessing the effects of TMS on the brains of patients with unipolar depression.
Who Is on the Research Team?
Joan Camprodon, MD, MPH, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for men and women aged 18-80 with a diagnosis of depression who need Transcranial Magnetic Stimulation (TMS) as part of their psychiatric care. It's not suitable for those with MRI contraindications, other primary mental health conditions like schizophrenia, active substance abuse in the past 3 months, or severe medical illnesses.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Transcranial Magnetic Stimulation (TMS) and are scanned using fcMRI before and after the treatment
Follow-up
Participants are monitored for changes in functional connectivity and clinical measures for depression severity and memory
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation is already approved in United States, Canada, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor